Lanhine Medical Announces 2026 FDA Registration Renewal: A Commitment to Global Compliance and Excellence

Zhejiang Lanhine Medical Products Ltd. is proud to announce the successful renewal of our FDA Registration for 2026 (Registration No. 3016654890). As a leading manufacturer of medical protection and health solutions, this milestone reinforces our dedication to meeting the highest international regulatory standards.

Why Our 2026 FDA Status Matters to Our Partners

In a shifting global market, compliance is the foundation of trust. Our active status ensures that our partners can import and distribute with full confidence:

  • Respiratory Protection: Full range of Level 1, 2, 3 and Type I, II, IIR Surgical Masks.

  • High-Performance Respirators: FFP2 respirators designed for hospital and industrial high-risk environments.

  • Innovative Care: Patented Fever-Reducing Gels and Liquid Bandages for the booming home healthcare market.

Advanced Manufacturing & Comfort

We go beyond basic compliance by focusing on user experience. Our Ultra-Breathable mask technology offers resistance $\le 15$ Pa while maintaining BFE $\ge 99\%$, ensuring safety without sacrificing comfort.

Partner with a Proven Leader

With robust OEM capabilities and strict quality control, Lanhine Medical empowers distributors across North America, Europe, and Asia. We invite you to explore our 2026-compliant solutions for your next bulk or custom order.


Post time: Feb-28-2026